Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Jolly Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Cash Flow Reinvestment Rate of 0.15x as of June 2025, reinvesting CN¥56.30 Million (capex CN¥19.94 Million plus investments CN¥-36.36 Million) from operating cash flow of CN¥367.02 Million. Explore 300181 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Cash flow reinvestment rate of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025. Historical reinvestment intensity for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Explore Zhejiang Jolly Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Zhejiang Jolly Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Jolly Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Jolly Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥412.14 Million | CN¥411.80 Million | CN¥287.14 Million | ▼ -28.3% |
| 2024 | 1.40x | CN¥414.53 Million | CN¥297.05 Million | CN¥262.89 Million | ▲ +1.8% |
| 2023 | 1.37x | CN¥395.29 Million | CN¥288.46 Million | CN¥131.71 Million | ▲ +88.0% |
| 2022 | 0.73x | CN¥232.28 Million | CN¥318.59 Million | CN¥178.03 Million | ▼ -26.9% |
| 2021 | 1.00x | CN¥251.15 Million | CN¥251.80 Million | CN¥147.95 Million | ▲ +116.1% |
| 2020 | 0.46x | CN¥129.08 Million | CN¥279.69 Million | CN¥58.35 Million | ▼ -25.8% |
| 2019 | 0.62x | CN¥80.22 Million | CN¥128.94 Million | CN¥40.46 Million | ▼ -83.0% |
| 2018 | 3.66x | CN¥286.30 Million | CN¥78.28 Million | CN¥153.92 Million | ▼ -84.3% |
| 2017 | 23.26x | CN¥151.37 Million | CN¥6.51 Million | CN¥124.40 Million | ▲ +266.4% |
| 2016 | 6.35x | CN¥370.19 Million | CN¥58.30 Million | CN¥143.24 Million | ▲ +132.5% |
| 2015 | 2.73x | CN¥265.21 Million | CN¥97.13 Million | CN¥26.08 Million | ▼ -4.8% |
| 2014 | 2.87x | CN¥39.30 Million | CN¥13.70 Million | CN¥39.30 Million | ▲ +256.8% |
| 2013 | 0.80x | CN¥23.73 Million | CN¥29.50 Million | CN¥23.73 Million | ▼ -33.8% |
| 2012 | 1.21x | CN¥37.05 Million | CN¥30.51 Million | CN¥37.05 Million | ▼ -73.0% |
| 2011 | 4.49x | CN¥61.32 Million | CN¥13.65 Million | CN¥61.32 Million | ▲ +652.1% |
| 2010 | 0.60x | CN¥38.68 Million | CN¥64.78 Million | CN¥38.68 Million | ▲ +33.7% |
| 2009 | 0.45x | CN¥19.60 Million | CN¥43.89 Million | CN¥19.60 Million | ▲ +11.3% |
| 2008 | 0.40x | CN¥12.50 Million | CN¥31.16 Million | CN¥12.50 Million | ▼ -29.4% |
| 2007 | 0.57x | CN¥9.12 Million | CN¥16.05 Million | CN¥9.12 Million | — |